Skip to content

Effectiveness of and Satisfaction With a Pharmacist-managed Travel Medicine Clinic

Determining the Clinical Effectiveness and Patient Satisfaction of a Pharmacist-managed Travel Medicine Clinic Under an Expanded Scope of Practice

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02625129
Enrollment
103
Registered
2015-12-09
Start date
2016-02-29
Completion date
2017-04-30
Last updated
2018-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Travel Medicine

Brief summary

This study will evaluate the clinical effectiveness of, and patient satisfaction with, pre-travel consultations provided by a pharmacist with specialty training in travel medicine and the authorization to prescribe medications and administer vaccinations.

Detailed description

The study will be conducted at the Travel Health Network, a full-service travel medicine clinic located in St. Albert, Alberta. Care will be provided by a pharmacist with a specialized practice in travel medicine, authorization to prescribe vaccines and prescription drugs, and authorization to administer vaccines by injection. The study will be a prospective mixed-methods cohort study, describing patients receiving care from a pharmacist-managed travel medicine clinic and their travel health needs, and evaluating their adherence to recommended vaccines and oral therapies, satisfaction with the care provided, and their health status and management of health issues arising while travelling. Chart reviews will elicit descriptive quantitative data related to patients' travel medicine needs and adherence to recommended vaccinations and oral pharmacotherapy, followed by surveys containing open-ended qualitative questions to elicit overall patient satisfaction and the management of any health issues encountered during travel. Due to the nature of the study involving patients presenting to the clinic for a consultation, neither a control group nor blinding is possible. A convenience sample of 100 subjects will be enrolled.

Interventions

OTHERPharmacist-provided travel care

Subjects will receive a pre-travel consultation from a pharmacist with specialty training in travel medicine, and with authorization to prescribe medications and vaccines and administer injections

Sponsors

University of Mississippi Medical Center
CollaboratorOTHER
Travel Health Network
CollaboratorOTHER
University of Waterloo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Receiving a pre-travel consultation at the Travel Health Network clinic in St. Albert, Alberta, Canada

Exclusion criteria

* Travellers with an expected return date after September 1, 2016 * Those receiving consultations as part of a group with the same itinerary (e.g., families, group vacations) will be asked to identify one member to participate in order to minimize repetition among participants.

Design outcomes

Primary

MeasureTime frameDescription
The proportion of recommended pre-travel vaccinations administered before departure according to chart reviewUp to 7 months.From date of pre-travel consultation until the date of travel departure according to participant's planned itinerary, assessed up to September 2016.
The proportion of recommended pre-travel oral pharmacotherapies dispensed before departure by a community pharmacy according to electronic health recordUp to 7 months.From date of pre-travel consultation until the date of travel departure according to participant's planned itinerary, assessed up to September 2016.

Secondary

MeasureTime frameDescription
Average satisfaction (along 1-5 scale) with care provided elicited through an online survey post-travel1 week following return from travel according to participant's planned itinerary
Frequency of reason(s) for declining any recommended vaccines or medications according to participant self-report through an online survey1 week following return from travel according to participant's planned itineraryResponse options: didn't feel I was at risk, cost, concern about vaccine ingredients or safety, other (specify)
Number of reports of any health issues over the course of travel according to participant self-report through an online survey1 week following return from travel according to participant's planned itineraryResponse options: Traveller's diarrhea, Altitude sickness, Malaria, Fever (Dengue, Chikungunya), Respiratory illness, Other (specify)
Frequency of management strategies of any health issues over the course of travel according to participant self-report through an online survey1 week following return from travel according to participant's planned itineraryResponse options: Nothing - it went away on its own, Took a non-prescription medication I had purchased before departure, Took a non-prescription medication I purchased while travelling, Called or emailed the Travel Health Network for advice, Searched the internet for guidance on how to manage it, Saw a physician while travelling, Saw a physician upon returning home, Other (specify)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026